Physician profile
Peter Ray
NPI 1477505956
$2,947.71
in general payments reported to CMS, 2019-2025
27 companies · $78.43 in 2025
The $78.43 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $430 · 2020: $505 · 2021: $522 · 2022: $658 · 2023: $511 · 2024: $244 · 2025: $78.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $833.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $832.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $539.09 | 2019-2022 | |
| Integra Lifesciences Corporation | $468.06 | 2020-2024 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Mentor Worldwide LLC | $373.80 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Smith+Nephew, INC. | $293.88 | 2019-2023 | Collagenase Santyl, Versajet, Oasis |
| Abbvie INC. | $264.47 | 2023-2024 | |
| Musculoskeletal Transplant Foundation INC. | $200.93 | 2019-2021 | |
| Stryker Corporation | $186.36 | 2019-2021 | |
| Axogen | $157.51 | 2019 | |
| Vericel Corporation | $64.36 | 2023 | Nexobrid |
| Innovation Technologies INC | $47.30 | 2020 | |
| Next Science LLC | $46.00 | 2020 | |
| Medline Industries Lp | $39.07 | 2019-2020 | |
| Avita Medical Americas, LLC | $30.74 | 2020 | |
| Ethicon US, LLC | $25.42 | 2019 | |
| Tela Bio, INC. | $19.35 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $19.34 | 2024 | |
| Kerecis Limited | $19.31 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Apyx Medical Corporation | $17.64 | 2020 | |
| Conmed Corporation | $16.99 | 2025 | System 2450 |
| Sientra, INC. | $16.62 | 2020 | |
| Elutia, INC. | $15.85 | 2021 | |
| Endo Pharmaceuticals INC. | $15.45 | 2019 | |
| Checkpoint Surgical, INC | $14.77 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $14.76 | 2022 | |
| Coopersurgical, INC. | $14.71 | 2025 | Insorb |
| Kci USA, INC. | $13.38 | 2022 | |
| Kls-Martin L.P. | $12.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Ray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.